The role of pullback pressure gradient in guiding coronary artery disease management

Kazumasa Ikeda1,2,3, Anthony Kechichian2,4, Ganeev Malhotra5

  • 1Clinical Trial Center, Cardiovascular Research Foundation, New York, NY, USA.

Future Cardiology
|May 24, 2026
PubMed

Insights

The pullback pressure gradient (PPG) offers a new way to assess coronary artery disease (CAD) severity, detailing pressure loss patterns. This metric helps predict improvements in blood flow and angina relief after treatment.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Interventional Cardiology

Background:

  • Coronary artery disease (CAD) is a major global health concern.
  • Current methods like fractional flow reserve (FFR) assess ischemia but lack spatial detail.
  • Optimizing treatment decisions requires integrating detailed coronary physiology.

Purpose of the Study:

  • To review current evidence on the pullback pressure gradient (PPG) in CAD.
  • To discuss the integration of PPG into clinical decision-making for CAD management.
  • To highlight PPG as a novel metric for characterizing pressure loss patterns.

Main Methods:

  • Review of existing literature on PPG and FFR.
  • Analysis of PPG's ability to differentiate focal vs. diffuse CAD.
  • Evaluation of PPG's predictive value for post-PCI outcomes.

Main Results:

  • PPG provides a continuous scale to characterize pressure loss along coronary arteries.
  • PPG values near 1.0 indicate focal CAD, while values near 0 suggest diffuse disease.
  • PPG has shown predictive value for improved blood flow and angina relief post-PCI.

Conclusions:

  • PPG is a valuable novel metric for detailed CAD assessment.
  • Integrating PPG into CAD management can optimize treatment strategies.
  • Further evidence supports PPG's role in predicting procedural success and patient outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...